What is RNA interference (RNAi)?

RNA interference (RNAi) is a gene-silencing mechanism that uses small RNA molecules to inhibit the expression of specific genes. RNAi function leads to the degradation of the targeted messenger RNA (mRNA) and the subsequent inhibition of protein synthesis when double-stranded RNA (dsRNA) molecules, such as small interfering RNA (siRNA), trigger the RNAi pathway. RNAi is an indispensable molecular biology tool for biomedical researchers studying gene manipulation and function in various organisms.

Discovery of RNAi: A Revolution in Gene Regulation

In the late 1990s, Fire and Mello discovered RNAi by injecting double-stranded RNA into Caenorhabditis elegans, leading to gene silencing and a new regulation mechanism. Identifying key molecules like Dicer and RISC was crucial, as it helped understand gene silencing. Advances in high-throughput screening and bioinformatics now enable the design of siRNAs for disease genes, paving the way for therapies and personalized treatments.

How RNAi Works?

RNAi Pathway Steps: From Initiation to mRNA Degradation

• Initiation - RNAi begins when dsRNA molecules enter a cell. These dsRNA molecules can originate from exogenous sources (e.g., synthetic siRNA, viral RNA) or endogenous sources (e.g., hairpin RNA, transposons).

• Dicer-Mediated Processing - Next, the enzyme Dicer cleaves dsRNA into smaller fragments called small interfering RNAs (siRNAs) or processes hairpin structures into microRNAs (miRNAs), which play a role in gene silencing via the RNAi pathway.

• RISC Loading - The RNA-induced silencing complex (RISC) selectively loads onto one strand of the siRNA (the guide strand), while the other (the passenger strand) siRNA strand is degraded. The guide strand determines the specificity of the RNAi process.

• Target recognition or Translation inhibition - The guide siRNA strand directs RISC to complementary mRNA sequences, typically in the coding region or untranslated regions (UTRs). The binding can occur either in the coding region or in the mRNA’s UTRs.

• Gene Silencing Mechanisms - Once bound, the RISC, along with the guide siRNA, can induce silencing through two main mechanisms

  • mRNA Degradation: The RISC, guided by the siRNA, can cleave the target mRNA at a specific site, leading to its degradation. This mechanism is commonly observed in plants and insects.
  • Translation Repression: The RISC can bind to the target mRNA without cleaving it, inhibiting protein synthesis. This mechanism is frequently observed in mammals.

Role of siRNA and miRNA in the RNAi Pathway

siRNA and miRNA are short RNA molecules that regulate gene expression by guiding the RISC complex to silence target mRNAs through complementary base-pairing interactions. By binding to their target mRNAs, siRNAs and miRNAs promote mRNA degradation or inhibit translation, thus controlling the expression of the associated genes.

Applications of RNAi

Gene Silencing

RNAi enables targeted gene knockdown, enabling selective gene silencing to study gene function and disease mechanisms.

Functional Genomics

RNAi has revolutionized functional genomics, enabling gene discovery in model and non-model organisms, including insects and crustaceans.

Therapeutic Applications

RNAi is being developed to potentially be used as a therapeutic modality against various diseases, including cancer, HIV/AIDS, genetic disorders and viral infections.

Drug Target Discovery

High-throughput RNAi screens help identify and validate novel drug targets by simplifying the identification of gene targets for human diseases, which can be validated using RNAi-based in vivo models.

Challenges and Limitations of RNAi

• Off-target Effects: Unintended gene silencing when the RNAi molecule binds to unintended targets. This can result in false positives or negatives in experimental results, making it difficult to interpret the data accurately.
• Delivery Method: Efficient delivery methods of RNAi molecules to target cells or tissues remain a hurdle. Non-viral vectors, bacterial vectors, lipid-based nanoparticles and liposomes show promise but require optimization for human therapeutic applications.
• Complex Patent Landscape: The complex intellectual property landscape can limit accessibility and innovation.

Advantages of RNAi

With RNAi’s high degree of specificity and efficiency, it can target any given gene or protein. RNAi can be used to:

• Identify and functionally assess genes within the genome for targeted phenotypes
• Block expression of a specific gene and evaluate the response to chemical screening or changes in the signaling pathway analysis
• Enable targeted temporal and spatial gene silencing, providing experimental flexibility

Future of RNAi: Trends and Innovations

Advancements in Delivery Methods

Advancements in delivery methods, such as nanotechnology-based systems and non-transgenic technologies, aim to overcome RNAi therapeutic hurdles. Research focuses on understanding siRNA delivery mechanisms and creating catalytic RNA vehicles to enhance RNAi-based cancer gene therapy.

Development of Novel RNAi-based Therapeutics

The future of RNAi is promising, with new therapeutics using targeted gene silencing to interfere with disease-related genes. Advances in chemistry, pharmaceutics and genome sequencing have sped up RNA treatments' development and clinical use.

Integration with other Technologies

The future of RNAi likely involves integrating with technologies like CRISPR-Cas9 to develop more precise gene editing tools. Combining RNAi and CRISPR-Cas9 could revolutionize gene therapy and enable personalized medicine.

The combination of RNAi and CRISPR-Cas9 technologies has the potential to revolutionize the field of gene editing tools. The combination of RNAi and CRISPR-Cas9 technologies has the potential to revolutionize the field of gene therapy and enable the development of personalized medicine.

recent-articles